
Shirley Ryan AbilityLab and Northwestern University have invented a new implantable drug delivery device.
Scientists, Yamin Zhang, Ph.D., and Colin Franz, MD, Ph.D. from Shirley Ryan AbilityLab, and John Rogers, Ph.D. from Northwestern University,
Scientists, Yamin Zhang, Ph.D., and Colin Franz, MD, Ph.D. from Shirley Ryan AbilityLab, and John Rogers, Ph.D. from Northwestern University,
Pfizer’s nasal spray, ZAVZPRET™, which treats migraines, has gained approval from the FDA. It is the first and only calcitonin
Aptar Pharma is launching APF Futurity, its first metal-free, designed-for-recycling multidose nasal spray pump for nasal saline and other over-the-counter pharma
The health insurer’s national formulary considers Amylyx Pharmaceuticals’ Relyvrio to be “experimental, investigational or unproven for any use,” and now
Kiora Pharmaceuticals, specialises in ophthalmology, developing treatment therapies for eye diseases. They have received approval for their new drug, KIO-101,
Chester Medical has ploughed just under £500,000 CAPEX investment as it continues to grow. With Jenny Dixon who joined Chester
Aptar Pharma, is a pharmaceutical leader in the manufacturing and development of drug delivery systems and solutions. They have launched
Explore Drug Solutions Podcast lates podcast as it looks back at the challenges and innovation highlights in 2022 for oral solid dosage forms, reviewing industry experts’ takes on factors driving the evolution of OSD forms and much more.
CSL has developed the first gene therapy for hemophilia B – now the most expensive drug in history.
TriMas Packaging has launched a new Rieke two-piece child-resistant cap designed to be child-resistant and meet the requirements of older
Lonza, a preferred partner to the pharmaceutical, biotech and nutraceutical markets, has launched an innovative new capsule solution for intestinal
Aptar Pharma, a world-leader in innovative drug delivery solutions and services and TFF Pharmaceuticals, a drug delivery and development company